PTCT
Ptc Therapeutics
$75.80
−$1.02 (−1.33%)Jul 27, 2026
Key metrics
The numbers that frame PTCT today
- Market cap
- $6.29B
- P/E (TTM)
- -33.7
- EV / FCF
- -25.8
- Gross margin
- 92.5%
- EV / Sales
- 7.1
- ROIC
- -6.7%
- Div yield
- 0%
- 52wk Low
- $43.18
- 52wk High
- $90.86
Growth
Revenue and earnings trend for PTCT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PTCT
Is Ptc Therapeutics a good buy?
Hold. Ptc Therapeutics has mixed quality and excellent momentum. The setup is mixed. Growth looks poor. That could put pressure on the long-term business case. We think Ptc Therapeutics is selling at a high price.
What is the market capitalization of PTCT?
Ptc Therapeutics's market capitalization is $6.29B.
What is the P/E ratio for PTCT stock?
Ptc Therapeutics's current P/E ratio is -33.7.
What is the 52-week high for PTCT stock?
The 52-week high for Ptc Therapeutics is $90.86. The current close of $75.80 is 16.6% below that high.
What is the 52-week low for PTCT stock?
The 52-week low for Ptc Therapeutics is $43.18. The current close of $75.80 is 75.6% above that low.
Does PTCT stock pay dividends?
Ptc Therapeutics does not currently show a dividend per share in the company data.